| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $634.4M | +1.4% | -0.7% |
| Cost of Revenue | $128.3M | +3.7% | +15.1% |
| Gross Profit | $506.1M | +0.8% | -4.0% |
| R&D Expense | $182.3M | -1.1% | -19.2% |
| SG&A Expense | $57.6M | -2.0% | -9.0% |
| Operating Income | $174.7M | +3.7% | +36.7% |
| Pre-tax Income | $157.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $730.7M | -0.8% | +41.2% |
| Accounts Receivable | $73.9M | -2.5% | +6.3% |
| Current Assets | $1.08B | -2.8% | +3.6% |
| Total Assets | $2.80B | +0.6% | +8.5% |
| Current Liabilities | $1.90B | +2.6% | +58.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $716.4M | — | — |
| Capital Expenditures | $10.5M | — | — |
| Investing Cash Flow | $66.0M | — | — |
| Financing Cash Flow | -$1.39B | — | — |
| Free Cash Flow | $705.9M | — | — |
| +6.4% |
| +18.5% |
| Income Tax | $33.4M | +50.5% | +28.5% |
| Net Income | $123.8M | -1.4% | +16.0% |
| EPS (Basic) | $0.47 | +2.2% | +38.2% |
| EPS (Diluted) | $0.47 | +4.4% | +38.2% |
| $4.33B |
| +5.9% |
| +38.6% |
| Stockholders' Equity | -$1.53B | -17.3% | -180.4% |